Paul Lacaze

6.9k total citations
103 papers, 1.8k citations indexed

About

Paul Lacaze is a scholar working on Genetics, Physiology and Molecular Biology. According to data from OpenAlex, Paul Lacaze has authored 103 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 22 papers in Physiology and 19 papers in Molecular Biology. Recurrent topics in Paul Lacaze's work include BRCA gene mutations in cancer (22 papers), Genetic Associations and Epidemiology (17 papers) and Lipoproteins and Cardiovascular Health (15 papers). Paul Lacaze is often cited by papers focused on BRCA gene mutations in cancer (22 papers), Genetic Associations and Epidemiology (17 papers) and Lipoproteins and Cardiovascular Health (15 papers). Paul Lacaze collaborates with scholars based in Australia, United States and United Kingdom. Paul Lacaze's co-authors include Jane Tiller, John J. McNeil, Peter Fransquet, Joanne Ryan, Peter Ghazal, Margaret Otlowski, Moeen Riaz, Thorsten Forster, Robyn L. Woods and Ingrid Winship and has published in prestigious journals such as Nature Communications, Blood and Journal of the American College of Cardiology.

In The Last Decade

Paul Lacaze

96 papers receiving 1.8k citations

Peers

Paul Lacaze
Comparison fields: 5 of 135
  • Molecular Biology 591
  • Genetics 463
  • Immunology 293
  • Surgery 244
  • Public Health, Environmental and Occupational Health 212
Lili Milani Estonia
J. Wade Davis United States
Qiu Zhao China
Manshu Song China
Neil Miller United States
Eva Lundin Sweden
Brian H. Shirts United States
José L. Gómez United States
М. И. Воевода Russia
Lili Milani Estonia View profile →
Citations per field, relative to Paul Lacaze
Paul Lacaze · 1×
Citations per year, relative to Paul Lacaze
Paul Lacaze · 1×

Countries citing papers authored by Paul Lacaze

Since Specialization
Citations

This map shows the geographic impact of Paul Lacaze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lacaze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lacaze more than expected).

Fields of papers citing papers by Paul Lacaze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Lacaze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lacaze. The network helps show where Paul Lacaze may publish in the future.

Co-authorship network of co-authors of Paul Lacaze

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Lacaze. A scholar is included among the top collaborators of Paul Lacaze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Lacaze. Paul Lacaze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Loss of Y Chromosome and Major Cardiovascular Events in a Prospective Study of Older Men Journal of the American College of Cardiology Peter Fransquet, David J. Curtis et al. 0
2 Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults JAMA Oncology Lê Thị Phương Thảo, Tri‐Long Nguyen et al. 0
3 Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults Clinical Pharmacology & Therapeutics Chad Bousman, Ankita Narang et al. 1
4 “Uninsurable because of a genetic test”: a qualitative study of consumer views about the use of genetic test results in Australian life insurance European Journal of Human Genetics Lyndon Gallacher, Louise Keogh et al. 1
5 Predictive Performance of an Updated Polygenic Risk Score for Age-Related Macular Degeneration Ophthalmology Chenglong Yu, Liubov D. Robman et al. 6
6 Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial The Journals of Gerontology Series A Zhen Zhou, Andrew Tonkin et al. 6
7 Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians Blood Advances Eileen Roulis, Simon J. Craddock Lee et al. 2
8 Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts Cancer Prevention Research Jonathan M. Downie, Moeen Riaz et al. 0
9 Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals Cancer Prevention Research Andrew Bakshi, Yin Cao et al. 3
10 Whole-genome sequencing analysis of clozapine-induced myocarditis The Pharmacogenomics Journal Ankita Narang, Paul Lacaze et al. 3
11 Protective lipid-lowering variants in healthy older individuals without coronary heart disease Open Heart Paul Lacaze, Moeen Riaz et al. 3
12 A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium Journal of Medical Genetics Jane Tiller, Louise Keogh et al. 7
13 Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population Aging Cell Moeen Riaz, Aamira Huq et al. 22
14 A polygenic risk score predicts mosaic loss of chromosome Y in circulating blood cells Cell & Bioscience Moeen Riaz, Jonas Mattisson et al. 7
15 Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis European Heart Journal Clara Marquina, Paul Lacaze et al. 24
16 Study protocol: the Australian genetics and life insurance moratorium—monitoring the effectiveness and response (A-GLIMMER) project BMC Medical Ethics Jane Tiller, Aideen McInerney‐Leo et al. 15
17 Genetic associations with clozapine-induced myocarditis in patients with schizophrenia Translational Psychiatry Paul Lacaze, Kathlyn J. Ronaldson et al. 26
18 Population Genomic Screening of All Young Adults in a Health-Care System: A Cost-Effectiveness Analysis Obstetrical & Gynecological Survey Lei Zhang, Yining Bao et al. 3
19 The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design European Journal of Human Genetics Paul Lacaze, Mark Pinese et al. 19
20 Penetrance and the Healthy Elderly Genetic Testing and Molecular Biomarkers Paul Lacaze, Ingrid Winship et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Milani Breakdown of academic impact, for papers by J. Wade Davis Breakdown of academic impact, for papers by Qiu Zhao Breakdown of academic impact, for papers by Manshu Song Breakdown of academic impact, for papers by Neil Miller Breakdown of academic impact, for papers by Eva Lundin Breakdown of academic impact, for papers by Brian H. Shirts Breakdown of academic impact, for papers by José L. Gómez Breakdown of academic impact, for papers by М. И. Воевода
Rankless by CCL
2026